Systemic blockade of P2X7 receptor protects against sepsis-induced intestinal barrier disruption

[1]  Xiongwen Lv,et al.  Purinergic P2X7 receptor mediates acetaldehyde‐induced hepatic stellate cells activation via PKC‐dependent GSK3&bgr; pathway , 2017, International immunopharmacology.

[2]  Chunping Zhang,et al.  Long noncoding NONRATT021972 siRNA normalized abnormal sympathetic activity mediated by the upregulation of P2X7 receptor in superior cervical ganglia after myocardial ischemia , 2016, Purinergic Signalling.

[3]  C. Coopersmith,et al.  The Gut as the Motor of Multiple Organ Dysfunction in Critical Illness. , 2016, Critical care clinics.

[4]  Yizhi Yu,et al.  Micheliolide inhibits LPS-induced inflammatory response and protects mice from LPS challenge , 2016, Scientific Reports.

[5]  R. Lockey,et al.  Deletion of P2X7 attenuates hyperoxia-induced acute lung injury via inflammasome suppression. , 2016, American journal of physiology. Lung cellular and molecular physiology.

[6]  V. Lupashin,et al.  Sepsis-induced elevation in plasma serotonin facilitates endothelial hyperpermeability , 2016, Scientific Reports.

[7]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[8]  Z. Cai,et al.  Suppression of P2X7/NF-κB pathways by Schisandrin B contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury , 2016, Archives of pharmacal research.

[9]  Daniel Mucida,et al.  Neuro-immune Interactions Drive Tissue Programming in Intestinal Macrophages , 2016, Cell.

[10]  S. Inoue,et al.  Sepsis induces incomplete M2 phenotype polarization in peritoneal exudate cells in mice , 2016, Journal of Intensive Care.

[11]  J. Qu,et al.  Rhein antagonizes P2X7 receptor in rat peritoneal macrophages , 2015, Scientific Reports.

[12]  M. Idzko,et al.  Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  E. Gilson,et al.  Genetic and pharmacological inactivation of the purinergic P2RX7 receptor dampens inflammation but increases tumor incidence in a mouse model of colitis-associated cancer. , 2015, Cancer research.

[14]  F. Di Virgilio,et al.  Accelerated tumor progression in mice lacking the ATP receptor P2X7. , 2015, Cancer research.

[15]  C. Takiya,et al.  The P2X7 Receptor Contributes to the Development of the Exacerbated Inflammatory Response Associated with Sepsis , 2015, Journal of Innate Immunity.

[16]  C. Scarpignato,et al.  Involvement of the P2X7 Purinergic Receptor in Colonic Motor Dysfunction Associated with Bowel Inflammation in Rats , 2014, PloS one.

[17]  Jie-shou Li,et al.  Cigarette smoking is associated with intestinal barrier dysfunction in the small intestine but not in the large intestine of mice. , 2014, Journal of Crohn's & colitis.

[18]  R. Coutinho-Silva,et al.  The role of p2x7 receptor in infectious inflammatory diseases and the influence of ectonucleotidases , 2014, Biomedical journal.

[19]  Gemma Odena,et al.  New method for isolation of rat lamina propria macrophages in colonic tissue. , 2014, Journal of immunological methods.

[20]  Yong-ming Yao,et al.  Macrophage Polarization in Inflammatory Diseases , 2014, International journal of biological sciences.

[21]  Fen Hu,et al.  Emodin inhibits ATP-induced IL-1β secretion, ROS production and phagocytosis attenuation in rat peritoneal macrophages via antagonizing P2X7 receptor , 2014, Pharmaceutical biology.

[22]  A. Schanaider,et al.  Prophylactic systemic P2X7 receptor blockade prevents experimental colitis. , 2014, Biochimica et biophysica acta.

[23]  R. Appelberg,et al.  Mycobacterium avium Infection Induces H-Ferritin Expression in Mouse Primary Macrophages by Activating Toll-Like Receptor 2 , 2013, PloS one.

[24]  M. Bissonnette,et al.  Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. , 2013, The Journal of clinical investigation.

[25]  B. Wiedenmann,et al.  Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[26]  Wen He,et al.  Amelioration of IFN-γ and TNF-α-Induced Intestinal Epithelial Barrier Dysfunction by Berberine via Suppression of MLCK-MLC Phosphorylation Signaling Pathway , 2013, PloS one.

[27]  Y. Zhang,et al.  Camptothecin and cisplatin upregulate ABCG2 and MRP2 expression by activating the ATM/NF-κB pathway in lung cancer cells. , 2013, International journal of oncology.

[28]  Xia Li,et al.  Role of Kinase Suppressor of Ras-1 in Lipopolysaccharide-Induced Acute Lung Injury , 2012, Cellular Physiology and Biochemistry.

[29]  Takuya Suzuki.  Regulation of intestinal epithelial permeability by tight junctions , 2012, Cellular and Molecular Life Sciences.

[30]  John Doyle,et al.  Sepsis: Something old, something new, and a systems view. , 2012, Journal of critical care.

[31]  Philip N. Tsichlis,et al.  Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization , 2012, Proceedings of the National Academy of Sciences.

[32]  R. Coutinho-Silva,et al.  Characterizing the Presence and Sensitivity of the P2X7 Receptor in Different Compartments of the Gut , 2012, Journal of Innate Immunity.

[33]  T. Wynn,et al.  Protective and pathogenic functions of macrophage subsets , 2011, Nature Reviews Immunology.

[34]  T. Weng,et al.  Purinergic P2X7 receptor regulates lung surfactant secretion in a paracrine manner , 2011, Journal of Cell Science.

[35]  W. Junger,et al.  Hypertonic stress regulates T cell function via pannexin‐1 hemichannels and P2X receptors , 2010, Journal of leukocyte biology.

[36]  S. Gordon,et al.  Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.

[37]  H. Wong,et al.  Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response. , 2009, Recent patents on inflammation & allergy drug discovery.

[38]  T. Hohl,et al.  Monocyte-mediated defense against microbial pathogens. , 2008, Annual review of immunology.

[39]  D. Donnelly-roberts,et al.  Discovery of P2X7 receptor‐selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states , 2007, British journal of pharmacology.

[40]  I. Chessell,et al.  Direct labelling of the human P2X7 receptor and identification of positive and negative cooperativity of binding , 2007, British journal of pharmacology.

[41]  Geoffrey Burnstock,et al.  Physiology and pathophysiology of purinergic neurotransmission. , 2007, Physiological reviews.

[42]  M. Gatt,et al.  Review article: bacterial translocation in the critically ill – evidence and methods of prevention , 2006, Alimentary pharmacology & therapeutics.

[43]  D. Donnelly-roberts,et al.  A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat , 2006, Journal of Pharmacology and Experimental Therapeutics.

[44]  C. Ledent,et al.  ADENOSINE A2A RECEPTOR INACTIVATION INCREASES SURVIVAL IN POLYMICROBIAL SEPSIS , 2006, Journal of immunology.

[45]  D. Donnelly-roberts,et al.  Structure−Activity Relationship Studies on a Series of Novel, Substituted 1-Benzyl-5-phenyltetrazole P2X7 Antagonists , 2006 .

[46]  A. Malik,et al.  NF-κB activation as a pathological mechanism of septic shock and inflammation , 2006 .

[47]  A. Malik,et al.  NF-kappa B activation as a pathological mechanism of septic shock and inflammation. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[48]  Liqin Wang,et al.  ATP stimulates GRK-3 phosphorylation and beta-arrestin-2-dependent internalization of P2X7 receptor. , 2005, American journal of physiology. Cell physiology.

[49]  A. K. Ritchie,et al.  P2X7 Receptor Stimulation of Membrane Internalization in a Thyrocyte Cell Line , 2005, The Journal of Membrane Biology.

[50]  M. Fink.  Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness , 2003, Current opinion in critical care.

[51]  M. A. Gülpınar,et al.  Endothelin receptor blockers reduce I/R-induced intestinal mucosal injury: role of blood flow. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[52]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[53]  R. North,et al.  Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors. , 2000, Molecular pharmacology.

[54]  J. Romand.  Bacterial translocation in the critically ill , 1996 .

[55]  M. Howard,et al.  Interleukin 10 protects mice from lethal endotoxemia , 1993, The Journal of experimental medicine.